Cargando…
Eight years of experience with biological treatment in juvenile idiopathic arthritis
Autores principales: | Mourão, A F, Rodrigues, A, Vinagre, F, Sousa, E, Polido-Pereira, J, Macieira, C, Ramos, F, Costa, J, Gomes Pedro, J, Pereira da Silva, J, Fonseca, J E, Santos, M J, Canhão, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007811/ http://dx.doi.org/10.1186/1479-5876-8-S1-P64 |
Ejemplares similares
-
PReS-FINAL-2163: Disease activity in a juvenile idiopathic arthritis population after 5 years follow-up
por: Marques, R, et al.
Publicado: (2013) -
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
por: Marques, R, et al.
Publicado: (2010) -
Caspase-1 is active since the early phase of rheumatoid arthritis
por: Cascão, R, et al.
Publicado: (2010) -
PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
por: Marques, R, et al.
Publicado: (2013) -
Genetic Screening of Mutations Associated with Fabry Disease in a Nationwide Cohort of Juvenile Idiopathic Arthritis Patients
por: Gonçalves, Maria J., et al.
Publicado: (2017)